WHO warns of global antimicrobial resistance gaps ahead of World AMR Awareness Week

WHO’s latest findings, released ahead of World AMR Awareness Week, show that 173 countries have developed national plans to address AMR, more than double the 79 countries that reported having such plans in 2017.

SWITZERLAND – The World Health Organization (WHO) has warned that gaps in diagnostic testing, surveillance and treatment continue to undermine efforts to combat antimicrobial resistance (AMR), even as more countries adopt national action plans.

In 2023, approximately one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics, making common infections increasingly difficult to treat

Drug resistance also raises the risks associated with routine medical procedures, including surgery, childbirth and cancer treatment.

WHO’s latest findings, released ahead of World AMR Awareness Week, show that 173 countries have developed national plans to address AMR, more than double the 79 countries that reported having such plans in 2017.

However, implementation and financing remain significant challenges.

Only 22% of countries report having both adequate funding and fully implemented national AMR action plans.

This shortfall affects several stages of patient care, including infection prevention, diagnosis, treatment and the monitoring of drug resistance.

“National plans are essential for protecting the medicines that protect us, and the fact that most countries now have plans in place is great news,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

He called on governments to translate policy commitments into action by increasing investment in infection prevention, surveillance, equitable access to essential antimicrobials and quality diagnostic services.

He also emphasised the importance of preventing infections and using diagnostic tests to guide appropriate antibiotic treatment.

The findings come from the 2026 Tracking Antimicrobial Resistance Country Self-assessment Survey (TrACSS), which received responses from 183 countries, representing 94% of WHO Member States.

Diagnostic capacity remains limited

Access to reliable diagnostic testing remains a major weakness in national AMR responses.

Only 36% of countries report having a national reference laboratory equipped to test selected bacteria and fungi.

This is considerably below the global target of 80% of countries having comprehensive bacterial and fungal resistance testing capacity by 2030.

Limited testing capacity increases the likelihood that healthcare providers will prescribe ineffective or unnecessary antibiotics.

It also makes it harder to identify resistant infections and outbreaks, while inadequate surveillance data restrict efforts to track emerging resistance patterns and guide public health interventions.

Other gaps affect antimicrobial stewardship and monitoring.

Only 63% of countries report having guidelines for appropriate antimicrobial use, while just over half have surveillance systems to monitor national antibiotic consumption and track AMR levels.

To address these challenges, WHO has introduced two practical tools under its AMR Diagnostic Initiative.

The resources provide a prioritised catalogue of diagnostic tests and step-by-step guidance to help clinical laboratories identify bacterial and fungal infections.

For healthcare systems, diagnostic capacity and antimicrobial stewardship remain important operational and investment priorities.

Weak laboratory networks can delay appropriate treatment, increase pressure on healthcare facilities and complicate efforts to preserve the effectiveness of existing medicines.

Expanding access to quality diagnostics will also require investment in laboratory infrastructure, skilled personnel and reliable supply chains.

One Health approach takes centre stage

World AMR Awareness Week, to be observed from 18 to 24 November, seeks to raise awareness of drug resistance and to encourage action to prevent its emergence and spread.

The 2026 campaign theme, “One Health, one action: Prevent AMR now”, highlights the links between human, animal, plant and environmental health.

It calls on governments, farmers, veterinarians, environmental specialists and communities to strengthen efforts to prevent and contain antimicrobial resistance.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.

Visited 8 times, 8 visit(s) today

Newer Post

Thumbnail for WHO warns of global antimicrobial resistance gaps ahead of World AMR Awareness Week

ASLM to promote sustainable diagnostic investment at 2026 Africa health security conference

Older Post

Thumbnail for WHO warns of global antimicrobial resistance gaps ahead of World AMR Awareness Week

Gavi invests US$30M to solarise 1,700 health facilities across five countries

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *